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We undertook a randomized, double-blind, crossover study in 14 healthy women who were 
required to ingest a 6-day low protein diet supplemented with CaSR-AAA (calcium-sensing 
receptor-activating amino acids), DAA (dibasic amino acids) or methylcellulose capsules 
(control). All subjects ingested all three diets in random order. Prior to each experimental diet 
subjects consumed an 11 day adjustment diet. Calcium absorption was measured on day 5 of 
each dietary intervention using dual-stable calcium isotopes. The clinical trial tested the 
hypothesis that dietary protein affects the efficiency of intestinal calcium absorption by activating 
the calcium sensing receptor (CaSR). Supplementation with CaSR-AAA did not significantly 
increase Ca absorption.  However, a trend towards improved Ca absorption was observed with 
DAA (25.2±1.4% vs. 22.3±1.4%, P=0.094).  
To further elucidate the mechanisms by which dietary protein improves Ca absorption, we 
established and validated a 45Ca in vitro transport model.  Differentiated Caco-2 cells were 
exposed to different concentrations of amino acids for 6 and 72 hours.  Prolonged amino acid 
treatment significantly enhanced total transepithelial Ca transport (P=0.0048).  
Subsequent in vitro studies utilized our recently validated transport model and focused on the 
functional role of Cldn-2 in total transepithelial Ca transport. Cldn-2 is a tight junction protein that 
was previously shown to be upregulated by dietary protein in rats.  Total transepithelial Ca 
transport was significantly reduced when Cldn-2 was stably knocked down in Caco-2 cells (P<  
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0.0001). The contribution of Cldn-2 to amino acid-induced increases in Ca transport will be 
explored in future studies. 
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Chapter 1: 
Introduction 
 
There is an increasing interest in finding dietary alternatives for both prevention and treatment of 
bone loss as osteoporosis continues to afflict an estimated 10 million people in the United 
States. Environmental factors such as nutrition play an important role in causing and preventing 
osteoporosis. In particular, dietary protein is an important nutrient that affects the way our 
bodies handle Ca. The primary focus of this dissertation was to begin to elucidate the 
mechanisms by which dietary protein improves Ca absorption efficiency by pursuing three 
specific aims: 1. determining which functional group of amino acids is most responsible for the 
effects of dietary protein on intestinal calcium absorption, 2. developing an in vitro transport 
system to assess the direct effect of amino acid on enterocyte Ca transport, 3. evaluating the 
functional role of tight-junction protein Claudin-2 (Cldn-2, a gene hypothesized to be involved in 
dietary protein’s effects on Ca absorption) in total transepithelial Ca transport.  
Chapter 2 reviews macronutrient regulation of intestinal Ca handling.  The chapter summarizes 
epidemiological, clinical, animal and in vitro research that explores the effects of carbohydrates, 
fat and/or protein on Ca absorption and transport.  
Chapter 3 is currently in the first review for publication in The Journal of Nutrition. This chapter 
is dedicated to specific aim 1, that is to determine which functional group of amino acids is most 
responsible for the effects of dietary protein on intestinal calcium absorption. This human 
intervention trial sought to recapitulate the effect of increasing dietary protein on Ca absorption 
by adding selected groups of amino acids to a low protein diet (0.7 g/kg/d) such that their total 
dietary content is equal to that of our previously published high-normal protein diet (2.1 g/kg/d). 
Supplementing a low protein diet with dibasic amino acids (arginine and lysine) resulted in a 
trend towards increased Ca absorption. 
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Chapter 4 contains in vitro experiments designed to pursue specific aim 2 and 3. We developed 
a 45Ca transport model in Caco-2 cells to assess the direct effect of amino acids on enterocyte 
Ca transport. Our preliminary results demonstrate significant increases in total transepithelial Ca 
transport with prolonged, but not acute, amino acid treatments. Alternatively, we utilized our in 
vitro model to evaluate the role of Clnd-2 in total transepithelial Ca transport. Previously, Cldn-2 
was identified as a tight-junction protein whose expression is increased in rats consuming a high 
protein diet. This novel finding fostered further investigation of this gene in Ca transport. Stable 
suppression of Cldn-2 resulted in a significant reduction in total transepithelial Ca transport. 
Future studies will evaluate the functional role of Cldn-2 in amino-acid induced increases in Ca 
absorption. 
Chapter 5 summarizes finding from the in vivo and in vitro studies presented in Chapters 3 and 
4.  As a follow up to the completed experiments, potential studies addressing current research 
gaps are proposed in this chapter.    
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Chapter 2: 
Macronutrient regulation of calcium transport: a mini-review 
 
Introduction 
Dietary Ca is absorbed by both transcellular and paracellular mechanisms. When Ca intake is 
low, the ATP-dependent transcellular calcium transport pathway predominates in the upper 
duodenum.  The three step process involves: apical Ca entry via Transient Receptor Potential 
cation channel, subfamily V, member 6 (TRPV 6) and to a lesser extent, by TRPV 5, facilitated 
diffusion of Ca by calbindin-D9k and basolateral extrusion via plasma membrane Ca ATPase 
(PMCA1b) or the Na+/Ca2+-exchanger (NCX1) (1).  Down regulation of the transcellular Ca 
transport pathway results from a normal or high dietary Ca intake, and in turn, paracellular Ca 
absorption increases throughout the small intestine (2). Passive Ca absorption has previously 
been defined as ion selective diffusion through the tight-junction of epithelial cells. However, 
increasing interest in the area of heritable disease states has drawn attention to the protein 
composition of the tight junction (1). The tight junction is comprised of transmembrane proteins, 
cytoplasmic scaffolding proteins and cytoskeletal proteins that create a dynamic and regulated 
environment. Particularly, transmembrane proteins, claudins (Clnds) and occludin, have a 
functional role in selective ion permeability (1, 3, 4). For instance, Cldn-2 forms channels that 
increase tight junction permeability of water and sodium (5, 6).  
Vitamin D is the most well-established nutritional regulator of Ca absorption (2). 1,25-
dihydroxyvitamin D mediates active Ca transport by increasing expression of brush-border 
membrane Ca channels, calbindin-D9k and the basolateral extrusion system (1). 1,25-
dihydroxyvitamin D increases the expression of two Ca-selective tight junction pore formers, 
Cldn-2 and -12, which suggests a novel regulatory function of vitamin D in paracellular Ca 
transport (7).  Alternatively, macronutrient regulation of Ca absorption has been an area of 
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much debate for over half a century. This mini-review summarizes past and emerging research 
demonstrating modulation of the Ca absorption pathway, with a primary emphasis on the 
paracellular transport route, by dietary carbohydrates, fat and protein, and calls attention to 
areas requiring further investigation.  
Effect of select carbohydrates on calcium absorption  
Since the 1940’s, milk has gained the attention of nutritionists for its rich Ca content and impact 
on bone health (8).  Therefore, it is not surprising that other constituents of milk have been 
evaluated for their potential Ca absorption enhancing properties. The lactic acid byproduct from 
the metabolism of “milk sugar” or lactose by lactobacilli was previously hypothesized to lower 
pH content of the gastrointestinal tract, providing a mechanism by which lactose increases Ca 
absorption (9). The acidic pH hypothesis was briefly replaced with the theory that certain mono-, 
di- and oligosaccharides are osteogenic stimulators (10). However, research demonstrating the 
rapid acting effects of lactose on Ca absorption challenged the bone cell theory, and the 
potential Ca absorption/retention enhancing properties of lactose were revisited. Subsequent 
studies in rats demonstrated an increase in femur 85Sr uptake (considered an index of Ca 
absorption) following co-administration of Ca and lactose in a segment of the ileum compared to 
Ca alone, or Ca and lactose in adjacent segments (11). An acute oral dose of lactose enhanced 
Ca absorption above that seen with the control dose, and to a slightly greater extent than lysine 
treatment (11), which has also been proposed to increase Ca absorption in rats and humans 
(12, 13).  Conversely, two week feeding of glucose or lactose had no effect on 45Ca femur 
content (11).  However, injecting carbohydrates including lactose into ileal sacs from rats 
resulted in increased 45Ca femur content with all administered carbohydrates within 4 hours 
after treatment. The slow rate of carbohydrate absorption was proposed as the mechanism by 
which carbohydrates exert an effect on Ca absorption, thus enabling them to reach the lower 
segment of the small intestine.  The enhancing effect was not observed in the duodenum (9). 
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Additional research in animal models corroborates these findings (14, 15). These results 
suggest that carbohydrates including lactose, glucose, sucrose and fructose would more likely 
exert an effect on the paracellular absorption route rather than the transcellular Ca transport 
pathway, as the predominate enhancing effect was observed in the ileum and not the 
duodenum (2). Furthermore, TRPV6, the primary apical transporter involved in transcelluar Ca 
transport, is highly expressed in the duodenum, and present at a much lower extent in the 
ileum, making it less likely that the aforementioned carbohydrates would impact TRPV6 
expression (1).  
Schuette and colleagues undertook a jejunal perfusion study in 16 healthy adults to assess the 
effect of lactose and the combination of glucose and galactose on calcium absorption (16). 
Lactose did not significantly alter Ca absorption compared to control or treatment with 
glucose/galactose.  Yet, glucose/galactose, the monosaccharides found in lactose, significantly 
increased net Ca absorption compared to mannitol (control). Water and sodium permeability 
paralleled Ca absorption. A solvent-drag effect was proposed as the mechanism by which 
simple carbohydrates could enhance paracellular Ca absorption. More recently, a cross-over 
trial in eleven lactose tolerant men and women examined the effect of lactose on fractional Ca 
absorption using pharmokenetics of orally administered strontium (17). Subjects ingested a 
bolus of lactose, glucose and galactose, or control (strontium alone) in random order. Food 
record analysis revealed consistency in kcals, carbohydrate, fat, protein, calcium and 
phosphorus intake between the three study groups 4-days prior to each Ca absorption 
assessment. There were no significant differences in Ca absorption 240 min after ingestion of 
either carbohydrate bolus or control, suggesting a one-time bolus of lactose is ineffective in 
enhancing Ca absorption in this population. However, the study had limitations. Compared to 
the oral strontium bolus employed by Zittermann et al. to evaluate fractional Ca absorption, 
dual-stable Ca isotopes would have provided a more accurate assessment as they are 
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considered the preferred methodology (18). Dietary intake prior to each absorption test was not 
tightly controlled.  The relatively small sample size and short duration may have precluded the 
investigators from capturing a measurable effect. Lastly, the decline in lactase from childhood to 
adulthood is well-established, with the majority of the world’s adult population being effected 
(19). Thus, it is not unreasonable to question the appropriateness of the selected population.  
Population based studies have demonstrated that for a variety of ethnic groups expression of 
lactase is much higher in infancy than in adulthood (20), suggesting that lactose 
supplementation in the early stages of life may provide beneficial effects.  An acute study in 
tube fed preterm infants examined the effect of lactose and glucose polymers on Ca absorption 
(21). Ca absorption was higher in the presence of glucose polymers compared to lactose. The 
study evaluated Ca absorption 1 hour post feeding and did not assess the impact of chronic 
carbohydrate ingestion on intestinal Ca handling. In a second study of longer duration, Ca 
absorption was evaluated by dual-stable Ca isotopes in 18 infants receiving both lactose and 
lactose-free, maltodextrin based formulas in a randomized, cross-over fashion (22). 
Consumption of lactose containing formula for two weeks resulted in significantly higher Ca 
absorption.  Zinc absorption was unaltered by the carbohydrate composition of the formula, 
suggesting that the effect of lactose may be specific to Ca. Lactose as well as other 
carbohydrate based formulas may enhance Ca absorption in infancy.  However, the overall 
effect of carbohydrates on Ca economy throughout the lifespan is, if at all, modest and requires 
further investigation. 
Effect of certain fatty acids and total fat intake on calcium absorption and transport 
The effect of fatty acids, most notably conjugated linoleic acid (CLA), on calcium transport has 
been investigated in Caco-2 cells. Jewell and Cashman assessed calcium transport in fully 
differentiated Caco-2 Bbe cells after acute and chronic exposure to linoleic acid, capric acid, 
lauric acid, a CLA blend or CLA isomers (23). Total transepithelial 45Ca transport and estimated 
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transcellular Ca transport were unaffected by both acute and chronic fatty acid treatments. 
Compared to the control treatment (vehicle), chronic exposure to capric acid, lauric acid, and 
trans-10, cis-12 CLA isomer significantly increased fluorescein flux, a non-specific marker of 
paracellular permeability, and decreased TEER. Conversely, subsequent reports have 
demonstrated significant increases in total transepithelial, transcellular and paracellular calcium 
transport in 14-day old Caco-2 cells exposed to CLA isomers (24, 25). Specifically, Jewell et al 
reported the addition of cis-9, trans-11 or trans-10, cis-12 CLA isomers to regular culture media 
for 14 days significantly augmented the three assessments of Ca flux compared to vehicle or 
linoleic acid treatment (24). Murphy et al demonstrated a significant increase in Ca transport 
after 12 days of  trans-10, cis-12 CLA isomer treatment compared to linoleic acid treatment (25). 
Alternatively, transport was unaltered in cells exposed to the cis-9, trans-11 CLA for 12 days. 
The inconsistencies in culturing periods between Jewell and Cashman’s report and the two later 
studies may explain their discrepant findings. Although Jewell et al reported no differences in 
alkaline phosphatase and aminopeptidase N activity in cells cultured for 14 days versus 22 days 
(24), the activity of brush border membrane enzyme sucrase-isomaltase has been shown to 
change throughout a 21 day culture period (26).  Transport of 45Ca was 1.8-fold higher in vehicle 
treated cells cultured for 14 days compared to cells cultured for 22 days (23, 24). Additionally, 
paracellar transport of fluorescein was approximately 9.4-fold higher in cells exposed to trans-
10, cis-12 CLA for 12 days with a culture period of 14 days compared to a 22 day treatment and 
culture period (23, 25), which provides evidence for differences in monolayer leakiness over 
various culturing periods.  Furthermore, passage number of Caco-2 cells, which was not 
documented by Jewell and Cashman (23) or Murphy et al (25) can influence the expression of  
nutritionally relevant  transporters and activity of brush border enzymes (27), and may have 
contributed to the observed difference.  
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Murphy and colleagues also investigated fatty acid-induced alterations in global gene 
expression in Caco-2 cells. Expression of calcium transport regulatory proteins, VDR and 
calbindin D9k, and tight junction protein, Clnd-4, were found to be upregulated more than 2-fold 
by trans-10, cis-12 CLA isomer relative to linoleic acid treatment, which is consistent with the 
observed isomer-specific effects on calcium transport. No effect was seen with cis-9, trans-11 
CLA treatment.  The authors noted that this is the first study to employ whole genome-wide 
microarray screen to investigate the effects of different CLA isomers on genes involved in 
calcium transport in an in vitro model of the intestines.  This study provides mechanistic insight 
into isomer-specific CLA induced increases in calcium transport. The increases in gene 
expression of VDR and calbindin D9k by trans-10, cis-12 CLA provides rationale for the 
observed increase in transcellular calcium transport.  However, it is currently unclear as to how 
the significant induction in Claudin-4 expression directly relates to calcium transport in the 
intestine. Claudins are a family of transmembrane proteins which have been shown to regulate 
paracellular transport of ions and water through the tight junctions of epithelia (28). A number of 
tissues including the intestine and the renal collecting duct have been shown to express 
Claudin-4 (29, 30). Claudin-4 has been characterized as a seal-forming claudin (31), however, 
in the presence of Claudin-8 has been shown to form a Cl¯ specific channel in the tight junctions 
of renal collecting duct cells (32). It is important to note that Murphy et al also demonstrated a 
significant increase in Claudin-2, a calcium permissive tight junction protein (7), in response to 
trans-10, cis-12 CLA by microarray screen, but this finding was not confirmed by quantitative 
RT-PCR (25).  More research regarding the effect of CLA isomers on claudin proteins in relation 
to paracellular calcium permeability is warranted.   
The association between dietary fat intake and Ca absorption was recently examined in a 
retrospective analysis of dual-stable isotopic studies in postmenopausal women (33).   Dietary 
fat intake was positively associated with true fractional Ca absorption. The strongest association 
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for fat intake and Ca absorption was seen in overweight women compared to obese and lean 
women. Stepwise multiple regression analysis revealed that dietary fat intake was the second 
most significant predictor of Ca absorption in all women. Neither carbohydrate nor protein intake 
were independent predictors of Ca absorption in this model. However, predictors of Ca 
absorption differed for premenopausal women, as fat intake was not considered an independent 
predictor of Ca absorption for this age group. The data suggests that dietary fat intake may have 
Ca absorption enhancing properties in older, but not younger women.  Similarly, a stepwise 
analysis of three dual-stable Ca isotope studies in 50 post-menopausal women found fat intake 
to be a significant predictor of fractional Ca absorption (34).  However, intervention trials 
assessing the impact of dietary fat on Ca absorption at different stages of life are required to 
better understand the interplay between dietary fat, age and Ca absorption in women.  
Effect of dietary protein and select constituents on calcium absorption 
Controversy continues to surround the effect of dietary protein on intestinal Ca absorption. Hunt 
et al (35) and Ceglia et al (36), reported no differences in calcium absorption between different 
levels of dietary protein when calcium intakes met or surpassed the RDA (35, 36) and dietary 
phosphorous was not fixed (36). Higher calcium and phosphorus intakes could have masked 
any potential regulatory actions of dietary protein on calcium absorption. Conversely, studies 
using dual stable Ca isotopes report that in the short term, dietary protein profoundly affects 
intestinal Ca absorption. In particular, Kerstetter et al demonstrated that as compared to a high 
protein diet (2.1 g protein/kg/d), restricting dietary protein to 0.7 g protein/kg/d results in 
hypocalciuria caused by a reduction in fractional intestinal Ca absorption (37). Additionally, 
increasing dietary protein from 1.0 to 2.1 g protein/kg/d resulted in an increase in urinary 
calcium that is not accompanied by evidence for increased bone resorption. The incremental 
change in urinary calcium can be nearly quantitatively explained by the improvement in 
intestinal calcium absorption that accompanies the increase in dietary protein (38). In this 
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experiment natural food stuffs were used and the dietary content of calcium, sodium and 
phosphorus were controlled so that they were the same or very similar on both the 1.0 g/kg and 
2.1 g/kg protein diets. Dietary protein was increased using both animal and vegetable protein 
sources.  
The constituents of dietary protein responsible for the previously observed increases in Ca 
absorption are unknown.  In particular, caseinphosphopeptides (CPPS) which are a component 
of milk as well as a digestion product of casein have been hypothesized to increase Ca 
absorption.  Ca binding to CPPS maintains Ca solubility and increases the bioavailability of Ca 
in the small intestine (39).   However, data in animal models have provided inconsistent results. 
The effect of CPPS on Ca absorption was previously assessed in normal and rachitic chicks 
using inverted gut sacs and ligated duodenal loop methodology (40).  Ca absorption was 
increased by CPPs in the duodenum and ileum in both chick models.  Phosphate, which may be 
released during the absorption of CPPS, had not effect on Ca absorption. These data suggest 
that the effect of CCPS on Ca absorption may be independent of vitamin D and phosphate.  In 
overiectomized rats the effect of CPPS on Ca absorption was dependent on Ca intake (41).  
Alternatively, an acute study in rats evaluated changes in Ca absorption when whey was 
replaced with casein and mixed protein sources including CPPS.  Type of protein source had 
not effect on Ca absorption (42).  A randomized, double-blind crossover study in 
postmenopausal women examined the effect of a one-time dose of CPPS-supplemented milk 
on urinary Ca (UCa) (43).  CPPS-supplemented milk did not enhance UCa compared to control 
milk. The study possessed some major limitations. There was no adjustment period prior to the 
first dietary intervention and UCa collection.  Besides Ca, other nutrients known to affect Ca 
absorption were not controlled for between study visits and Ca absorption was not directly 
measured. A more recent crossover, intervention trial assessed the effect of a one-time CPPS 
bolus on intestinal Ca handling using dual stable Ca isotopes and reported no increase in Ca 
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absorption with CPPS compared to control (44). Thus, the acute intervention period may not 
have been of sufficient duration to see an effect.  
There are obviously other components of dietary protein that could be responsible for the 
previously observed increases in Ca absorption (37, 38). In particular, amino acids have been 
hypothesized to have a direct effect on enterocyte Ca transport. Chapters 3 and 4 summarize 
the current evidence supporting the role of amino acids in Ca absorption and paraceullular Ca 
transport. In chapter 3 we evaluate the effect of select groups of amino acids on Ca absorption 
in vivo. Subsequently, the potential mechanism by which amino acids exert an effect on the 
enterocyte is explored in Chapter 4. 
Conclusion 
Macronutrient regulation of Ca absorption continues to be an area of much debate.   Past and 
current evidence concerning these nutrients is suggestive of macronutrient-induced alterations 
in paracellular Ca transport, rather than transcellular pathway activation.  It may be that 
macronutrient regulation occurs at different critical stages throughout the lifespan, such as 
infancy, childbearing years and post-menopause, with each macronutrient exerting an effect at 
different periods. It would be of interest to examine the impact of macronutrients on intestinal Ca 
handling in different age groups and sexes in longer-term clinical trials, as the response is likely 
to vary between the different groups.  
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Chapter 3: 
Supplementing a low protein diet with dibasic amino acids results in higher 
urinary calcium excretion in young women 
 
Introduction 
For nearly 90 years, we have known that dietary protein affects calcium metabolism (45). In a 
meta-analysis of 26 clinical intervention trials in adults where dietary protein was manipulated 
and urinary calcium was measured, there was a strong linear correlation of the two (46) such 
that on average, for every 40 g increment in dietary protein, urinary calcium increases by 50 mg. 
It was widely assumed that the skeleton was the principal source of the additional calcium. 
Higher protein diets, particularly those including animal sources, generate a fixed metabolic acid 
load due to the metabolism of sulfur-containing amino acids. The diet-induced acid load is 
believed to be incompletely accommodated by renal mechanisms, therefore, requiring release 
of buffer from bone. The liberation of alkali from bone requires osteoclast-mediated bone 
resorption, which could over a prolonged period of time reduce skeletal mass (47-50). In support 
of this hypothesis, balance studies in the 1970’s reported no change in intestinal calcium 
absorption as dietary protein increased (51-57). However, more recent studies using dual stable 
calcium isotopes found that in the short term, dietary protein significantly affects intestinal 
calcium absorption (37, 38). In particular, Kerstetter et al demonstrated that increasing dietary 
protein from 1.0 to 2.1 g/kg results in an increase in urinary calcium that is not accompanied by 
evidence for increased bone resorption. The increment in urinary calcium observed by these 
investigators was nearly quantitatively explained by a parallel improvement in intestinal calcium 
absorption (38). Recent work using an experimental rat model found a similar effect of dietary 
protein on intestinal calcium absorption (58). Initial rates of calcium uptake were increased in 
brush border membrane vesicles (BBMVs) isolated from rats acclimated to a high protein diet 
(40%) compared to BBMVs from rats consuming a low protein diet (5%), suggesting that protein 
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augments intestinal Ca absorption at least in part by increasing transcellular Ca uptake. The 
constituents of protein-containing foods that are responsible for its effect on intestinal calcium 
absorption remain unclear. One obvious candidate is amino acids.  
Amino acids could impact calcium absorption by altering cellular metabolism in enterocytes or 
act as extracellular agonists via cell surface receptors or acceptors. Regarding the latter 
possibility, amino acids are known to be allosteric activators of the calcium-sensing receptor 
(CaSR), which is expressed throughout the gastrointestinal tract (59). Phenylalanine, tryptophan 
and histidine are the most potent activators of the CaSR (60, 61). Conigrave et al. (60) first 
reported amino acid-induced activation of the CaSR at physiologic extracellular calcium 
concentrations in HEK cells engineered to overexpress the receptor. Busque et al. (62) reported 
that L- phenylalanine and L-tryptophan at concentrations comparable to those seen post-
prandially can stereoselectively allosterically activate the CaSR on gastric parietal cells both in 
vivo and ex vivo. Work by Dawson-Hughes et al. (63) provides further evidence in support of the 
hypothesis that the CaSR could mediate dietary protein-induced increases in intestinal calcium 
absorption. They demonstrated that supplementing a low protein diet with phenylalanine and 
histidine increased urinary calcium; although they did not directly measure intestinal calcium 
absorption. Another group of amino acids that appears to have effects on intestinal calcium 
absorption are the dibasic amino acids. In particular, dietary lysine supplementation was 
reported to increase calcium absorption in individuals with osteoporosis (13).  The mechanism 
by which lysine supplementation induces changes in calcium absorption efficiency is unclear 
and is likely  independent of CaSR activation because lysine is minimally effective as a CaSR 
agonist (60).  
Despite these data, whether specific amino acids or dietary protein as a whole is responsible for 
the protein-induced increases in calcium absorption remains unresolved. The current human 
intervention trial was designed to determine if supplementing a low protein diet (0.7 g/kg) with 
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the CaSR activating amino acids (CaSR-AAA), tryptophan, phenylalanine and histidine, or the 
dibasic amino acids (DAA), arginine and lysine, augments intestinal calcium absorption to an 
extent comparable to that seen when dietary protein is increased from low to high.  
Methods 
Subjects 
Sixty-five women (20-40 years old) with a body mass index (BMI, kg/m2) ranging from 18 to 28 
were screened for eligibility. Subjects were recruited through flyers and advertisements in the 
Yale Bulletin between the years 2010 and 2012. Recruitment was limited to non-Hispanic 
Caucasian or Asian adults because these two ethnic groups are at highest risk for osteoporosis 
(64). Potential subjects were excluded if they were taking medications known to affect calcium 
metabolism (anti-osteoporotic medications, glucocorticoids, non-steroidal anti-inflammatory 
medications, and birth control pills); were pregnant; reported excessive body weight change 
during the past 6 months; followed intensive physical exercise regimens; smoked; had an eating 
disorder, food allergies or followed medically prescribed diets; or had renal, gastrointestinal, or 
bone disease; or amenorrhea. Subjects were asked to stop taking all multivitamin or mineral 
supplements during the entire study. Throughout the study, subjects continued their usual 
activities at home, school, or work except on days 5 and 6 of the three experimental periods, at 
which time they were admitted to the Hospital Research Unit (HRU) of the Yale Center for 
Clinical Investigation for measurement of calcium absorption. The study was approved by 
human investigation committees at Yale University and the University of Connecticut. Informed 
consent was obtained from each participant. 
Experimental Design  
Diets: The study protocol included 3 cycles, each consisting of an 11 day adjustment diet 
followed by 6 days of an experimental diet.  The three experimental low-protein diets (control, 
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CaSR-AAA supplementation, DAA supplementation) were provided in random order. The 
experimental and adjustment diets are similar to those described in previous reports (37, 38, 
65). The Yale Center for Clinical Investigation Research Dietitian and her staff prepared all 
meals for every study subject during the feeding portion of the study (last 3 days of the 
adjustment diet and 6 days of the experimental diet). For the first 8 days of each adjustment 
period, subjects were instructed by the research dietitian to self-select their diets to contain a 
dietary protein intake of 1.2 g/kg, 2300 mg (100 mmol) of sodium and 800 mg (20 mmol) of 
calcium. The low-protein experimental diet (0.7 g/kg) consisted of variety of foods common to 
the western diet and contained 800 mg (20 mmol) calcium, 2300 mg (100 mmol) sodium, 800-
1,200 mg (26–39 mmol) phosphorus and 13 grams of fiber. For each study subject, food items 
remained the same on all three experimental diets. Each subject began with an energy intake of 
30-36 kcal/kg (125–150 kJ/kg) and which was adjusted in 200-300 kcals/kg (840–1260 kJ/kg) 
increments (with simple sugars and fats) during the experimental period to maintain body weight 
within 1% of initial weight. The macronutrient and mineral composition of the experimental diets 
was calculated from the U.S. Department of Agriculture Handbook No. 8 and manufacturer’s 
information. The primary sources of calcium in the experimental diets were dairy foods and a 
chewable calcium carbonate (Tums, GlaxoSmithKline, Pittsburgh, PA). Caffeine-containing 
beverages were limited to one a day and alcohol was not permitted. Distilled water was 
provided ad libitum. After the final urine collection on day 6, subjects resumed their usual, 
unstructured diet, and subsequently participated in the second and third dietary cycles.  
Amino Acid Supplements: L-amino acids were purchased from Ajinomoto Pharmaceuticals 
(Ajinomoto Food Ingredients LLC, Chicago IL, 60631) and dispensed in capsules by the Yale 
Investigational Drug Pharmacy. The total milligrams of supplemental amino acids for a given 
day were divided among the three meals in amounts proportional to the total protein in each 
meal. The amount of each amino acid added to the low-protein diet was the amount contained 
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in the 1.4 g/kg increment in dietary protein required to increase protein intake from low (0.7 
g/kg) to high (2.1 g/kg) (i.e. 2.1 - 0.7 = 1.4). Depending on a subject’s body weight, this required 
between 5 and 7 capsules with each meal.  
The average amino acid content (mg) per gram of total protein in the low and high protein diets 
(shown in Table 1) was used as the basis for determining amino acid supplementation (37, 38). 
A 60 kg female is used in the following example illustrating how amino acid supplementation 
was calculated for the study. The baseline low protein diet for a 60 kg female subject would 
contain 42 grams of protein (0.7 g/kg x 60 kg) consumed over 3 meals. The subject would 
require 126 grams of protein (2.1 g/kg x 60 kg) on the high protein study diet. The increment in 
dietary protein required to increase her protein intake from 0.7 g/kg to 2.1 g/kg is 84 grams. This 
subject’s three experimental diets will be:  
1. 42 g of protein plus placebo (methylcellulose).  
2. 42 g of protein plus 2268 mg of histidine (27* X 84), 6384 mg of phenylalanine (76* X 
84) and 924 mg of tryptophan (11* X 84). 
3. 42 g of protein plus 4368 mg of arginine (52* X 84) and 5628 mg of lysine (67* X 84). 
* These values were obtained by averaging the amino acid content of the low and high protein 
diets previously utilized by Kerstetter et al (37, 38) and represent the mg of each amino acid per 
gram of dietary protein (last column of Table 1). 
Biochemical Sample Collection: Between Days 0 and 1 and Days 4 and 5, subjects collected 
24-hr timed urine excretions for measurement of calcium, phosphorous, and sodium. On Day 1 
and 5 of the experimental diet fasting blood was drawn for measurements of serum 1,25-
dihydroxyvitamin D, parathyroid hormone (PTH) and creatinine. Glomerular filtration rate (GFR) 
was estimated from serum creatinine, age, sex, and race using the National Kidney Foundation 
on-line calculator MDRD study equation. Serum levels of 25-hydroxyvitamin D were determined 
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and corrected (if needed) in each study subject prior to beginning each adjustment diet to 
assure a vitamin D-sufficient status. If the serum 25-hydroxyvitamin D was less than 67 nmol/L 
but greater than 50 nmol/L subjects received a one-time correction dose of 50,000 IU of vitamin 
D2. Subjects with a serum 25-hydroxyvitamin D level less than 50 nmol/L were given two 
correction doses of 50,000 IU of vitamin D2 separated by five days.  Serum 25-hydroxyvitamin D 
was retested at least two weeks after supplementation. Subjects were not permitted to start their 
adjustment diet until their serum 25-hydroxyvitamin D was at least 67 nmol/L. 
Measurement of Intestinal Calcium Absorption: Intestinal calcium absorption was measured 
using dual stable calcium isotopes as previously described (38). In brief, 0.125 mg of 44Ca/kg 
body weight was administered orally in 3 divided doses with each meal in proportion to the 
calcium content of the meal. The isotope was equilibrated in milk for 18-24 hours prior to 
administration. Immediately after the breakfast meal on day 5, 0.02 mg of 42Ca/kg (for 
experimental diets 1 and 3) or 0.004 mg/kg of 43Ca (for experimental diet 2) were administered 
intravenously, after which urine was collected for the next 34 hours in three urine pools (8h, 12h, 
14h). The intravenous isotope was changed for every other experimental diet to ensure that 
there was no carryover of isotope from one diet to the next.  
Calcium isotope ratios were measured using a Thermo Scientific Triton TI magnetic sector 
thermal ionization mass spectrometer (TIMS; Thermo Fisher Scientific Inc, Bremen, Germany). 
A ratio was made between each administered calcium tracer (42Ca, 43Ca and 44Ca) and another 
naturally occurring calcium isotope (i.e.: 48Ca). Fractional calcium absorption was determined as 
the ratio of the cumulative oral tracer recovery to the cumulative IV tracer recovery in the 34-h 
urine collection obtained post-dosing. True calcium absorption was calculated as the product of 
fractional calcium absorption and the calculated calcium intake (38). 
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Assays: Twenty four hour urinary calcium, urinary phosphorous and serum creatinine were 
measured on an AlfaWasserman ACE® analyzer (Alfa Wassermann Diagnostic Technologies, 
LLC, West Caldwell, NJ). Urinary sodium was measured in the Clinical Chemistry Laboratory of 
the Yale–New Haven Hospital. Intact PTH was measured by radioimmunoassay (Total Intact 
PTH Assay, Scantibodies Laboratory Inc, Santee, CA). Vitamin D metabolites were measured 
by radioimmunoassays (Diasorin, Inc Stillwater, MN).  
Statistical Analyses: The estimated number of subjects required to detect a change in calcium 
absorption is based on the hypothesis that adding CaSR-AAA to a low-protein diet will increase 
intestinal calcium absorption to an extent similar to that observed when the subject’s dietary 
protein intake is increased from 0.7 to 2.1 g/kg.  Since it is possible that amino acids besides 
those that activate the CaSR also affect intestinal calcium absorption, we estimated the effect 
size for the CaSR-AAA to be approximately 70% of that seen with the 2.1 g/kg diet.  We 
reported that increasing dietary protein from 0.7 to 2.1 g/kg increased calcium absorption from 
19 ± 5.0% to 26 ± 8.0% (an increment of 7±6.5%; P<0.01) (37).  As just noted, to be 
conservative we estimated an effect size approximately 30% less than that (a 5±6.5% increase 
in calcium absorption).  Using this effect size and standard deviation, a sample size of 14 
provides a power of 0.80 with P=0.05 (calculated using GraphPad StatMate® version 2.0a for 
Macintosh; GraphPad Software, San Diego, CA). 
Analyses were performed using SPSS version 12.0 for Windows (SPSS Inc, Chicago, IL). The 
graphical summary was generated using Prism software (version 4.0, 2004, GraphPad 
Software). All values are presented as means ± SEM. The Shapiro–Wilks test was used to test 
data for normality. All data were normally distributed except for serum 25-hydroxyvitamin D and 
24-h urinary calcium at baseline and intact PTH at baseline and day 5 of all three interventions. 
A repeated measures ANOVA or Friedman test (for non-normally distributed data) was used to 
assess differences in baseline measures between the three experimental diets. A paired t-test 
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or Wilcoxon signed ranked test (for non-normally distributed data) was used to assess 
differences between each amino acid supplementation group and the control diet at day 5 and 
differences between baseline (day 1) and day 5 of each experimental diet. A comprehensive 
assessment of the primary outcome variable, intestinal calcium absorption, was performed by 
calculating mean effect sizes for the two interventions. This was done by the following 
calculation: mean absorption on the amino acid supplemented diet for the entire study group 
minus the mean absorption on the control diet for all study subjects divided by the standard 
deviation of the difference  between the control diet and each amino acid supplemented diet 
(66). A probability level of P ≤ 0.05 indicated statistical significance and P > 0.05 but < 0.10 
indicated a trend.   
Results 
Figure 1 summarizes study subject recruitment, enrollment and randomization. Of the 65 
subjects screened for eligibility, 51 subjects did not meet the inclusion criteria or were not 
interested in participating after receiving a detailed explanation of the study. Fourteen healthy 
premenopausal women with a mean age of 27.8 ± 1.2 and a BMI of 23.7 ± 0.9 were enrolled 
and randomized. 
Serum and Urine Metabolites  
Serum 25-hydroxyvitamin D was within normal limits at the start of each subject’s adjustment 
diet and was not significantly different between the three dietary interventions (control: 88.1 ± 
4.8 nmol/L, CaSR-AAA: 88.1 ± 4.6 nmol/L, DAA: 87.5 ± 4.3 nmol/L, P=0.67) (67). Baseline 
measures of serum and 24-h urine metabolites did not differ significantly between the three 
diets (Table 2). Changes observed in calcium-related metabolites during the three experimental 
diets are presented in Table 2. No significant differences were observed in 1,25-
dihydroxyvitamin D or intact PTH between baseline and day 5 of each intervention. Analyses of 
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the day 5 values for PTH and 1,25-dihydroxyvitamin D revealed no significant differences 
among the three interventions. Urinary sodium and GFR remained stable with no significant 
differences observed at any time point for the duration of the study. As expected, GFR was 
above 60 mL/min/1.73 m2 in all subjects throughout the entire study period. At day 5 urinary 
calcium was lower than the value at baseline in all three experimental diets, however, this 
change only reached statistical significance during the control diet (control: 37.4% mean 
decrease, Z=-2.67, P=0.008; CaSR-AAA: Z=-0.91, P=0.36; DAA: Z=-1.48, P=0.14). At day 5, 
urinary calcium was significantly greater with the DAA supplementation than the control diet 
(P=0.039) (Table 2, Figure 2A). Twenty four-hour urinary phosphorus on day 5 of the three 
study diets was found to be significantly lower than at baseline (control: P=0.001, CaSR-AAA: 
P=0.047, DAA: P= 0.008).  
Calcium Absorption 
As shown in Table 2, there was no significant difference in calcium absorption between the diet 
supplemented with CaSR-AAA and the control diet at day 5 (effect size = 0.12 ± 0.09, P=0.64). 
However, there was a non-significant trend toward increased calcium absorption with DAA 
supplementation as compared to the control diet (P=0.094), with 10 of the 14 subjects 
evidencing higher absorption. Because dietary calcium was fixed at 20 mmol/d, intestinal 
calcium absorption on the low protein diet supplemented with DAA was 0.6 ± 0.3 mmol/d higher 
than on the control diet. Calculation of effect size revealed that this observed difference in mean 
intestinal calcium absorption is considered to be a medium effect (0.54 ± 0.1) (68). As can been 
seen in Figure 2, the increase in intestinal calcium absorption mirrored the change in urinary 
calcium observed during the two diets. The mean difference in urinary calcium at day 5 between 
the control and DAA supplemented diets was 0.9 ± 0.4 mmol/d.   
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Discussion 
We employed dual stable calcium isotopes to evaluate the effect of a low-protein diet 
supplemented with either DAA or CaSR-AAA on intestinal calcium absorption. The intestinal 
handling of calcium was not influenced by the addition of CaSR-AAA to a low protein diet. Short-
term supplementation with DAA resulted in a significant increase in urinary calcium and 
augmented calcium absorption without significant changes in PTH or 1,25-dihydroxyvitamin D 
during the three diet interventions, suggesting that the change in calcium excretion is due to 
improved intestinal calcium absorption and not an induced renal calcium leak.  
It is traditionally assumed that the dietary protein-induced increases in urinary calcium results 
from the release of skeletal buffer and calcium in response to the metabolic load imposed by 
sulfur-containing amino acids (47-50). Our data provide evidence for amino acid-induced 
increases in urinary calcium independent of changes in dietary sulfur content, since arginine 
and lysine do not contain sulfur. Therefore, the observed increase in urinary calcium is very 
likely attributable to the rise in intestinal calcium absorption, rather than an increase in skeletal 
catabolism.  
Our laboratory has previously reported increased intestinal calcium absorption during a high-
normal protein diet (2.1 g/kg), consisting of both animal and vegetable protein, when compared 
to both low (0.7g/kg) and medium (1.0 g/kg) protein intakes (37, 38). In these prior studies dual 
stable calcium isotopes were also used to assess calcium absorption, calcium was fixed at 19.8-
20 mmol/d and nutrients known to affect calcium metabolism were tightly controlled. Under 
these study conditions, when dietary protein was increased from 0.7 to 2.1 g/kg, intestinal 
calcium absorption rose by 36.8% (37). The current study supplemented the same low protein 
diet with the amount of the amino acids contained in the 1.4 g/kg increment in dietary protein 
that was required to increase protein intake from 0.7 to 2.1 g/kg. Intestinal calcium absorption 
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was 13% higher with dibasic amino acid supplementation compared to the low-protein control 
diet. The change in calcium absorption in the present study reflects roughly a third of the 
change in absorption observed when dietary protein was increased by 1.4 g/kg using mixed 
food sources. Thus, the addition of DAA to the low protein diet did not increase intestinal 
calcium absorption to the same extent as when dietary protein sources were manipulated. 
However, DAA supplementation resulted in a quantifiable change in intestinal calcium 
absorption which can explain 67% of the 0.9 mmol change in urinary calcium. Since intestinal 
calcium absorption declines with aging and after menopause even a modest improvement in 
intestinal calcium absorption could have long-term physiological significance.  Thus, most 
estrogen-deficient postmenopausal women are in negative calcium balance and an intervention 
that improves calcium homeostasis could potentially protect against long-term deleterious 
effects on skeletal integrity. 
Research in animal models supports an effect of DAA on calcium economy (12, 69). Over 50 
years ago, Wasserman et al. (69) measured 45Ca in the femur of young male rats after the 
enteral administration of an individual amino acid bolus. Of the ten essential and eight non-
essential amino acids studied, L-lysine followed by L-arginine resulted in the greatest 
accumulation of 45Ca in bone. Compared to the control animals, administration of L-lysine and 
L-arginine caused 1.7-fold and 1.6-fold increases in 45Ca accretion in bone, respectively. In 
subsequent work, these investigators evaluated the interaction between lysine and other 
nutrients known to effect calcium metabolism in vitamin D deficient rats (12). Treatment with L-
lysine or vitamin D enhanced calcium absorption above that seen with control treatment, but not 
to the same extent as when they were provided in combination. The authors hypothesized that 
L-lysine and vitamin D may be acting via different cellular pathways to increase intestinal 
calcium absorption. Taken together, the studies by Wasserman et al and the present study 
support the notion that additional studies to clarify the role of DAA in calcium metabolism are 
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warranted. At present, it is unclear if DAA exert an effect on the transcellular, paracellular or 
both calcium transport mechanisms.  
The current study also evaluated a second group of amino acids (phenylalanine, tryptophan and 
histidine) because they allosterically activate the CaSR.  We found no effect of CaSR-AAA on 
calcium absorption. In contrast, we found an increase in urinary calcium from the DAA 
supplementation in comparison to the control. It is unlikely that the slight effect we observed of 
DAA on intestinal calcium absorption is mediated by the CaSR.  Conigrave et al. (60) 
demonstrated that arginine and lysine were not very effective in activating the CaSR in HEK-293 
cells stably expressing the receptor.   
Dawson-Hughes et al. (63) examined the effects of selectively supplementing a low protein diet 
with either CaSR-AAA, phenylalanine and histidine, or the branched chain amino acids (BCAA), 
isoleucine and leucine, on urinary calcium. There was no significant difference in urinary 
calcium between baseline and day 11 of amino acids supplementation for either study group or 
between the two study groups at the end of the supplementation period. These findings are 
consistent with the results of the present study where we found no significant change in urinary 
calcium with CaSR-AAA supplementation. In a subsequent analysis, mean change in 24-hr 
urine calcium was also compared between to the two groups (63). The addition of CaSR-AAA to 
a baseline low protein intake of 0.5 g/kg resulted in an 11±9 mg increase in calcium excretion, 
which was significantly different from the 20±9 mg decline in urinary calcium observed with 
BCAA supplementation. In contrast to our study, urinary calcium did not change from baseline 
during the two amino acid interventions. The dietary intervention used by Dawson-Hughes et al 
differed from the current study in that it contained 0.2 g/kg less dietary protein, 16.1 mg/kg more 
histidine and 52.5 mg/kg less phenylalanine. Differences in study design, study duration and 
amino acid supplementation may have contributed to the discrepancy in directional change in 
urinary calcium between the present study and the report by Dawson-Hughes et al. 
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A BCAA intervention was not included in the present study. Two human clinical trials found no 
effect of BCAA supplementation on urinary calcium or calcium absorption (13, 63). Civitelli et al 
supplemented osteoporotic patients with three different amino acids including the BCAA, L-
valine, which did not induce a rise in intestinal calcium absorption (13). Similarly, Dawson-
Hughes et al. (63) reported a blunted calciuric response in subjects consuming a diet rich in 
leucine and isoleucine compared to those with high CaSR-AAA intakes. There are obviously 
numerous other combinations of amino acids that need to be explored in relation to calcium 
homeostasis, which is beyond the scope of this study.  
Not all investigators have observed an effect of dietary protein on calcium absorption. Hunt et al 
(35) and Ceglia et al (36), reported no differences in calcium absorption between different levels 
of dietary protein when calcium intakes met or surpassed the RDA (35, 36) and dietary 
phosphorous was not fixed (36). Higher calcium and phosphorus intakes could have masked 
any potential regulatory actions of dietary protein on calcium absorption. It would be of interest 
to examine the effect of graded calcium intakes in conjunction with different quantities or 
combinations of amino acid supplements on calcium economy to determine if this has a 
protective effect on calcium homeostasis in low dietary calcium environments. 
The current study had a number of strengths including a tightly controlled cross-over design with 
all meals provided by the metabolic kitchen at the Yale Center for Clinical Investigation. Good 
dietary compliance was evident by consistency in urinary sodium. We targeted young Asian and 
Caucasian women as these ethnic groups are at highest risk for osteoporosis in later adult life 
(64). A recent analysis of NHANES (2003-2006) reported that women between the ages of 19-
40 who do not use calcium supplements are not meeting the current recommendations for 
calcium (70). Thus, young Asian and Caucasian women would likely benefit from a nutrient 
based, low-risk, therapeutic option, such as dietary protein/amino acid supplementation, to 
maximize calcium absorption. Moreover, protein intake has decreased in women from 1970's to 
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2006 (71).  We chose to study a group of individuals who, as they age, are at greatest risk for 
osteoporosis and depending on dietary protein intake could benefit from protein/amino acid 
supplementation to optimize intestinal calcium absorption.    
The study also had some limitations. Our sample size was small. It may be that larger studies of 
longer duration will be needed to further clarify the impact of DAA on calcium economy. Some 
subjects required vitamin D supplementation prior to starting their adjustment diets. However, 
the number of study subjects requiring vitamin D supplementation was nearly equal for each 
dietary intervention (DAA: 7 subjects, CaSR-AAA: 8 subjects, Control: 8 subjects) making 
unlikely that this confounded our results. Time of menstrual cycle was not controlled for when 
scheduling each study subject’s calcium absorption assessments. In initial studies from our 
group examining the effect of increasing protein intake on calcium absorption using the same 
dual-stable calcium isotope methodology as in our current report, we did not control for time of 
menstrual cycle in premenopausal women (37, 38). We observed a quantitatively comparable 
effect of dietary protein in men and postmenopausal women in whom cyclical changes in 
reproductive hormone levels do not occur when compared to premenopausal women. Thus, 
although we cannot exclude a contribution of variations in estrogen levels to our observed 
results, given the above, this seems unlikely to have made a major contribution.  
In summary, calcium absorption was assessed by dual-stable calcium isotopes in healthy 
premenopausal women consuming a low-protein diet supplemented with CaSR-AAA or DAA for 
six days. The addition of CaSR-AAA to a low-protein diet did not result in a significant rise or 
decline in calcium absorption. Urinary calcium was significantly higher with arginine and lysine 
supplementation, which could potentially be explained by a change in calcium absorption 
efficiency.  
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FIGURE LEGENDS 
FIGURE 1 Flow diagram displaying recruitment, enrollment and randomization of study 
subjects. Fourteen healthy young women took part in a cross-over design, feeding study where 
they received three experimental diets in random order (control; CaSR-AAA, CaSR-activating 
amino acids; DAA, Dibasic amino acids). n=14 for each experimental diet. 
FIGURE 2 Mean urinary calcium (A) and intestinal calcium absorption (B) for fourteen healthy 
young women on day 5 of the control and DAA supplemented low-protein diets. n=14 for each 
experimental diet. Significantly different from the control diet by paired t-test: *P< 0.05, 
**Different from control, P value > 0.05 and < 0.10, suggestive of a trend, ***Effect size = 0.54 ± 
0.1. DAA, Dibasic amino acids.
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Table 1  Average amino acid content per gram of total protein in the low and high protein study diets1  
Amino acid   
Amino acid 
functional group   
Amino acid content of low 
protein diet                         
(mg/g dietary protein)   
Amino acid content of 
high protein diet                                
(mg/g dietary protein)   
Average amino acid content of 
the diets2                                       
(mg/g dietary protein) 
His 
 
CaSR-AAA 
 
25.3±0.6 
 
28.2±0.2 
 
27 
 
        
 
Phe 
 
CaSR-AAA 
 
75.4±0.8 
 
76.5±0.6 
 
76 
 
        
 
Trp 
 
CaSR-AAA 
 
11.3±0.2 
 
11.3±0.0 
 
11 
 
        
 
Arg 
 
DAA 
 
46.5±1.2 
 
56.8±0.4 
 
52 
 
        
 
Lys   DAA   58.9±1.1   74.9±0.8   67 
1 Values are presented as means ± SEM.   
2 Average amino-acid content of the low and high protein diets was used to calculate amino acid supplementation. 
CaSR-AAA, CaSR-activating amino acids; DAA, Dibasic amino acids. 
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Table 2 
 
Effect of CaSR-AAA and DAA supplementation on calcium-related metabolites and calcium absorption in young women1 
          
Control CaSR-AAA Supplementation DAA Supplementation 
          Day 1 Day 5 Day 1 Day 5 Day 1 Day 5 
Subjects, n 
  14 14 14 14 14 14 
         
Serum metabolites 
         
1,25-Dihydroxyvitamin D (pmol/L) 151 ± 13 163 ± 8 162 ± 12 155 ± 12 172 ± 14 166 ± 13 
        
Intact PTH (nmol/L) 36 ± 6 31 ± 6 31 ± 7 30 ± 6 32 ± 9 31 ± 7 
 
 
GFR (mL/min/1.73 m2)                       91 ± 5  97 ± 6 90 ± 5  91 ± 6 93 ± 5 94 ± 6 
         
24-h urine metabolities  
 
Sodium (mmol) 90.8 ± 12.6 74.9 ± 6.7 80.9 ± 10.7 86.4 ± 8.2  80.2 ± 7.5  90.1 ± 9.7 
        
Calcium (mmol) 4.6 ± 1.1 2.9 ± 0.3 a 3.9 ± 0.6 3.3 ± 0.3 4.2 ± 0.6 3.8 ± 0.5 b 
 
Phosphorus (mmol) 18.4 ± 1.8 11.4 ± 1.2 a 15.6 ± 1.7 12.0 ± 1.2 a 18.2 ± 1.4 12.7 ± 1.3 a 
 
Calcium absorption 
  
 
Intestinal calcium absorption (%)   22.3 ± 1.4   22.9 ± 2.0   25.2 ± 1.4 c 
1Values are presented as mean ± SEM.  
aSignificantly different from baseline of same intervention, P < 0.05. 
bSignificantly different from control day 5, P < 0.05.  
cDifferent from control day 5, P value > 0.05 and < 0.10, suggestive of a trend. 
CaSR-AAA, CaSR-activating amino acids; DAA, Dibasic amino acids 
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FIGURE 1 
  
Assessed for eligibility 
(n = 65) 
Excluded (n = 51) 
• Not meeting inclusion 
criteria (n=20) 
• Declined to         
participate (n=31) 
Analyzed                                    
(n = 14) 
 
Excluded from analysis                 
(n = 0) 
Lost to follow-up 
(n = 0) 
Discontinued 
intervention           
(n = 0) 
Randomized to the three 
experimental diets (n = 14): 
• Control  
• CaSR-AAA   
• DAA 
Completed the three 
experimental diets (n = 14): 
• Control  
• CaSR-AAA  
• DAA  
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Chapter 4: 
Establishment of an in vitro transport model for evaluating the effects of amino 
acids and claudin-2 on total transepithelial Ca transport 
 
Introduction 
Controversy surrounds the role of dietary protein in calcium homeostasis. Dietary protein was 
thought to have deleterious effects on the skeleton because the endogenous acid load 
generated from the metabolism of sulfur-containing amino acids might induce osteoclast-
mediated bone resorption. The result is Ca being leached from bone as part of a homeostatic 
mechanism in which bicarbonate is released from mineralized tissue to buffer the acid (47-50). 
However, Kerstetter et al have demonstrated that moderate increases in dietary protein 
significantly improve intestinal Ca absorption, in least in the short-term, without increasing bone 
resorption (38).  
The underlying mechanism by which dietary protein increases Ca absorption is unclear.  
Gaffney-Stomberg et al. established an animal model to begin elucidating the mechanism for 
protein-induced increases in intestinal calcium absorption (58). Rats were randomly assigned to 
low (5%) or high (40%) protein diets for 7 days. All diets were isocaloric and contained 0.45% 
Ca and 0.35% P. In rats, UCa paralleled protein intake. Rats consuming the high protein diet 
absorbed and retained more Ca compared to the low protein group (48.5% vs. 34.1% and 
45.8% vs. 33.7% respectively, p<0.01). Brush border membrane vesicles (BBMV) were 
prepared from duodena of rats acclimated to the low or high protein diets. Ca uptake was 
significantly increased in BBMVs from animals on the high protein diet indicating that protein 
augments intestinal Ca absorption, in part, by increasing transcellular Ca uptake. However, the 
expression of the known plasma membrane Ca channels, TRPV5 and TRPV6, was not induced 
by a high protein diet (58). Since expression of TRPV5 and TRPV6 were not altered by dietary 
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protein, Dr. Insogna’s laboratory undertook a whole genome microarray screen using RNA 
isolated from duodenal enterocytes of rats ingesting the low or high protein diet to look for novel 
Ca transporters. Claudin-2 (Cldn-2) was found to be upregulated by the high protein diet in the 
microarray screen, a finding corroborated by qPCR, using duodenal RNA. Cldn-2 is a tight 
junction protein that exhibits Ca selectivity. Its expression is induced by 1,25-dihydroxyvitamin 
D. Increased expression of Cldn-2 at the tight junction increases calcium permeability (7). These 
findings suggest that dietary protein could be affecting calcium transport by a Cldn-2-dependent 
mechanism.   
The constituents of dietary protein responsible for the increases in Ca uptake and absorption 
are unknown. Furthermore, the function of Cldn-2 in total transepithelial calcium transport is not 
well established. To investigate the mechanisms by which dietary protein exerts its effects on 
intestinal Ca transport, and to determine if there is a direct effect of amino acids on enterocyte 
Ca transport, an in vitro Ca transport model was developed in Caco-2 cells. Since Cldn-2 was 
upregulated by dietary protein in our rat model, we also sought to determine the contribution of 
this endogenous protein to Ca transport. Toward this end, Cldn-2 was stably suppressed in 
Caco-2 cells and Ca transport was evaluated.  
 
Materials and Methods 
Materials 
Caco-2 Bbe cells were kindly provided by Dr. Mark Mooseker (Dept of Molecular, Cellular & 
Developmental Biology, Yale University) and purchased from America Tissue Culture Collection 
(Rockville, MD).  High-glucose DMEM, L-glutamine, D-glucose, phenol red powder, HEPES (≥ 
99.5%) and D-(+)-Raffinose pentahydrate were purchased by Sigma (St. Louis, MO).  Qualified 
FBS, L-glutamine, non-essential amino acids (NEAA), essential amino acids (EAA), puromycin 
dihydrochloride and penicillin/streptomycin were purchased from Gibco/Invitrogen (Carlsbad, 
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CA).  KCl, Na2HPO4, glycine and NaCl were purchased from Fisher Scientific (Suwanee, GA). 
KH2P04 and MgSO4 were purchased from J. T. Baker (Phillipsburg, NJ). OPTI-FLUOR LSC-
cocktail was purchased from Perkin Elmer, Inc (Waltham, MA). Collagen coated 
polytetrafluoroethylene Transwell permeable supports (Corning Incorporated, Costar, Corning, 
NY, catalog no. 3491) and Polyester Transwell permeable supports (Corning Incorporated, 
Costar, Corning, NY, catalog no. 3460) were purchased from Corning Incorporated. pGIPZ 
Lentiviral Human CLDN2 shRNA was purchased from Fisher Scientific – USA (Pittsburgh PA, 
catalog # RHS4531-EG9075). Lenti-X HTX Packaging System, Lenti-X Concentrator and Lenti-
X GoStixTM were purchased from Clontech (Mountainview, CA). iScript™ cDNA Synthesis Kit 
and iTaqTM Universal Probes Supermix were purchased from BIO-RAD Laboratories (Hercules, 
CA). Cldn-2 and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) TaqMan® Gene 
Expression Assays were purchased from Applied Biosystems (Foster City, CA).  Protease 
inhibitors were purchased from Roche Diagnostic (Indianapolis, IN).  Mouse anti-Cldn-2 
antibody was purchased from Invitrogen (REF325600). Mouse anti-β-actin antibody was 
purchased from Santa Cruz Biotechnology (sc-47778, Santa Cruz, CA).  
Cell culture 
Caco-2 cells were grown in T-75 flasks and routinely passaged using Trypsin/0.5% EDTA when 
80-90% confluent.  Cells were cultured in growth media containing high glucose DMEM, 10% 
qualified FBS, 1% L-glutamine, 1% non-essential amino acids and 1% penicillin/streptomycin 
and media was changed every 2-3 days. Caco-2 cells were maintained at 37ºC in a 5% CO2-
95% air atmosphere. Caco-2 cells provide a model of intestinal epithelia, as they exhibit brush 
border microvilli and apical enzymes including sucrase isomaltase, alkaline phosphatase and 
aminopeptidase N.  For over a decade Caco-2 cells have provided a well-established model for 
the assessment of small intestinal transcellular flux of a number of compounds that is predictive 
of in vivo absorption in humans (72, 73).  In most of the studies described below, Caco-2 cells 
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were studied at 21-days post-confluent at which time they are fully differentiated and assume an 
enterocyte phenotype (74-76). 
Amino acid treatments 
As shown in the Table, moderate amino acid (MAA) transport treatment consisted of 20 
essential and non-essential amino acids added to transport buffer (TB) and provided 1.914 mg 
of total amino acids/mL. The final concentration of amino acids provided by the MAA treatment 
was approximately 1.2-fold higher than the amount found in high glucose DMEM, the primary 
constituent of regular Caco-2 growth media.  High amino acid (HAA) transport treatment had the 
same amino acid profile as MAA and provided 5.276 mg of total amino acids/mL, which is 
approximately 3.3-fold higher than the concentration of amino acids in high glucose DMEM 
(Table).  Amino acid pretreatment was comprised of 1% FBS, penicillin/streptomycin and high-
glucose DMEM (1% FBS media) supplemented with MAA.  
Diffusional phenol red transport studies 
The methodology utilized in the current study for assessing diffusional phenol red flux across 
Caco-2 monolayers is a modification of that previously published (24, 77).  Phenol Red was 
used to provide a simple assessment of paracellular transport (77). For phenol red transport 
studies Caco-2 cells were seeded at a density of 3 X10^5 -5 X10^5 cells/well into 6-well plates 
containing collagen coated polytetrafluoroethylene Transwell permeable supports.  For these 
experiments, Caco-2 cells were studied at 21 days post-confluence. These culture conditions 
were chosen based on previous work by Suzuki and Hara who examined the effect of raffinose, 
along with other non-digestible saccharides, on paracellular permeability in Caco-2 cells (78).  
On the day of an experiment the media was removed and the inserts were rinsed two times with 
room temperature Dulbecco’s phosphate-buffered saline (PBS). The permeable supports 
containing the cells were transferred to fresh six-well plates containing 2.5 mL of freshly 
prepared TB ((in mM) 140 NaCl, 5.8 KCl, 1.2 CaCl2, 0.34 Na2HP04, 0.44 KH2P04, 0.8 MgSO4, 20 
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N-Z-hydroxyethylpiperazine-N’-2-ethanesulfonic acid, 4 glutamine, and 25 glucose, pH 7.37-7.4) 
(24, 76, 77). At time zero, 1.5 mL of transport buffer was added to the upper chamber of the 
Transwells inserts. Upper chamber buffer consisted of the same buffer as the lower chamber 
except it also contained Phenol Red (500 uM). Raffinose (100 mM), a non-digestible 
oligosaccharide, which non-specifically reduces transepithelial resistance (TER) and increase 
paracellular permeability in Caco-2 cells, was included in the TB as a positive control (78). 
Following the addition of transport buffer, cells were incubate at 37ºC in a 5% CO2-95% air 
atmosphere (with manual shaking approximately every 30 min for 45 seconds) for 90 minutes, 
120 minutes or 4 hours. At the end of each experiment, duplicate 300 ul aliquots of lower well 
buffer was removed and transferred to an eppendorf tube and 30 µl of 0.1 N NaOH was added 
to each sample.  Absorbance was read at 560 nm following a 5 min incubation period.  The 
concentration of phenol read appearing in the lower buffer after 90 minutes, 120 minutes and 4 
hours of transport was determined using a standard curve of phenol red.  
Total transepithelial 45Ca transport studies 
For total transepithelial 45Ca transport studies, Caco-2 cells were seeded into 12-well plates with 
Polyester Transwell permeable supports at a density of 56,000 cells/cm2. Similar techniques 
were utilized to assess the effect of various nutrients on calcium transport (23-25, 76, 77).  To 
validate the in vitro Transwell transport model 1,25-dihydroxyvitamin D, a known regulator of 
calcium transport (76), was used as a positive control.  Cells were pre-treated with 1, 25-
dihydroxyvitamin D in 5% FBS growth media for 24 hours prior to the start of the study. 1,25-
dihydroxyvitamin D validation experiments mimicked the 4 hour phenol transport studies 
summarized above, however, 45Ca was used in place of phenol red to assess total transepithial 
calcium transport. At Time 0, 45Ca was added to the upper chamber in the presence of TB 
(control) or TB to which 1,25-dihydroxyvitamin D (100 nM) had been added. Approximately 5-10 
min after addition of 45Ca triplicate 25 ul aliquots were removed from the top (baseline samples) 
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and bottom wells. After 4 hours, triplicate 50 ul samples were taken from the bottom chambers.  
Baseline and 4 hour samples were added to scintillation vials containing OPTI-FLUOR LSC-
cocktail. Radioactivity was determined using a liquid scintillation counter (Tri-Carb 2800TR). 
Total transepithelial Ca transport was estimated as the amount of 45Ca appearing in the 
basolateral buffer at 4 hours, expressed as a percentage of the total 45Ca applied to the upper 
chamber at Time 0. Studies to evaluate the effect of pH on epithelial permeability were 
conducted using the same methodology, except the duration of 45Ca transport measurements 
was extended to 6 hours and the duration of amino acid pretreatment varied as detailed below.  
Generation of stable Cldn-2 knockdown in Caco-2 Bbe by lentiviral vector 
Lentiviral preparations were generated according to the manufacturer’s instructions.  Briefly, 90-
95% confluent Lenti-X 293T packaging cells were transfected with pGIPZ Lentiviral vector 
containing tGFP reporter, puromycin resistance gene, and Cldn-2 specific or non-silencing 
shRNA (scrambled shRNA, control) using the Lenti-X HTX Packaging System.  Forty-eight 
hours after transfection, lentiviral supernatants were harvested and mixed with the Lenti-X 
Concentrator. Virus production was verified using Lenti-X GoStixTM.  Forty-eight hours prior to 
lentiviral transduction, Caco-2 Bbe cells were plated in 24-well plates at a density of 3.1X 104 
cells/well in their complete growth medium.  Caco-2 cells were transduced with viral supernatant 
using Polybrene (as per the manufacturer’s protocol), centrifuged at 2,000 RPM for 1.5 hours 
and incubated overnight.  Infected cells were incubated for an additional 48 hours in complete 
growth medium before the initiation of antibiotic selection with 8 µg/mL puromycin 
dihydrochloride (final concentration). Stable transfectants were routinely passaged using 
Trypsin/0.5% EDTA when 80-90% confluent.  Cells were cultured in normal growth media 
(described above) containing 8 µg/mL puromycin dihydrochloride with a media change every 2-
3 days. To assess infection efficiency, Caco-2 cells were imaged using fluorescence microscopy 
to visualize GFP expression.  
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Quantitative analysis of Cldn-2 knockdown by Real Time-PCR (qPCR) and Western blot 
qPCR 
Total RNA was isolated from approximately two week post confluent non-infected Caco-2 cells 
(control), or Caco-2 cells stably transduced with 5 different Cldn-2 specific shRNAs or 
scrambled shRNA GIPZ lentiviral constructs. cDNA was synthesized using the iScript™ cDNA 
Synthesis Kit and the RT reaction was performed on a PTC-100 PCR machine (MJ Research 
Inc., Waltham, MA) using the following protocol: 25°C x 10 min, 43°C x 45 min, 95°C x 5 min.  
qPCR was performed using a TaqMan® Gene Expression Assay for Cldn-2 (Rn02063575_s1) 
and iTaqTM Universal Probes Supermix. GAPDH was used as an endogenous reference 
(Hs99999905_m1). 
Western Blot 
Caco-2 cells were grown in 60 mm dishes and lysed with RIPA buffer (1% Triton-X 100, 1% Na 
deoxycholate, 0.1% SDS, 158 mM NaCl, 5 mM EDTA, 10 mM Tris pH 7.2) containing protease 
inhibitors (Roche Diagnostics Corporation, Indianapolis, IN). Cell lysates were removed using a 
plastic cell scraper.  Lysates were incubated on ice for 10 min and clarified, by centrifugation at 
14,000 x g for 15 min at 4°C. The clarified lysates were assayed for protein content using a 
BCATM protein assay (Thermo Scientific, Rockford, IL).  SDS-PAGE gel electrophoresis and 
western blotting were performed using standard techniques.  A mouse monoclonal antibody to 
Cldn-2 (2 ug/ul) that detects a band of approximately 22-23 kDa was added in 5% skim milk at 
4ºC overnight. A secondary antibody, anti-Mouse (1:1000), in 5% skim milk was applied for 1 
hour.  β-actin was used as a loading control.  
Statistics Analyses 
Statistical analyses and graphical summaries were performed using GraphPad Prism ® version 
6.00 for Windows (GraphPad Software Inc., La Jolla, CA). All values are presented as means ± 
SEM.  An unpaired t-test was used to analyze experiments conducted on two groups. When 
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three or more groups were studied an unpaired t-test were used to compare each experimental 
treatment to control of the same time point. For all statistical analyses, differences with a P 
value <0.05 were considered significant. 
 
Results and Discussion 
Transport of phenol red in Caco-2 monolayers grown on collagen coated polytetrafluoroethylene 
Transwell supports  
We initially attempted to assess paracellular Ca flux in Caco-2 cells using phenol red. Caco-2 
cells were treated either TB (control) or raffinose, which is known to non-specifically open the 
tight junction. Unexpectedly, treatment with raffinose for 90 minutes did not alter phenol red 
transport in Caco-2 cells. In fact, phenol red flux was suppressed in cells exposed to raffinose 
for 120 minutes (P = 0.006; Figure 1a).  To determine if the duration of exposure to raffinose 
was insufficient to measure an effect on paracellular transport, the treatment was extended to 4 
hours. Exposing Caco-2 cells to raffinose for 4 hours resulted in a 1.2-fold increase in phenol 
red transport compared to TB (control; P= 0.17; Figure 1b). The fact that phenol red was without 
a significant effect in this model prompted a reevaluation of all aspects of this in vitro system. 
Upon review it was noted that the collagen coated polytetrafluoroethylene Transwell supports 
used in this experiment have a membrane thickness of 50 µm which is five-times the thickness 
of polyester Transwell permeable inserts. We hypothesized that the relatively thick membrane 
represented a physical barrier that precluded us from detecting a change in paracellular Ca 
transport. We therefore, substituted the polytetrafluoroethylene supports for polyester inserts, 
and replaced phenol red with 45Ca, a marker specific for calcium flux, in an effort to improve the 
sensitivity and specificity of the model.  
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Validation of total transepithelial 45Ca Transwell transport model 
Transwell inserts with a semipermeable membrane were previously used to examine 
transepithelial, transcellular and paracellular transport pathways in the presence of various 
drugs and nutrients. Such a model requires independent validation as a wide variety of 
methodologies have been previously published (23-25, 72, 76, 77, 79). As expected, treatment 
with 1,25-dihydroxyvitamin D significantly increased transepithelial Ca transport (Figure 2; 2-fold 
increase; P=0.0132), indicating that this model responds normally to vitamin D. To further 
validate the model, the apical side of the Caco-2 monolayer was exposed to an acidic 
environment by the addition of a low pH buffer (pH = 3) to the upper chamber.  Total 
transepithelial Ca flux was 4.5-fold higher after treatment with an acidic buffer compared to TB 
with a neutral pH (Figure 3).  This observation is in agreement with in vitro work by Tang and 
Goodenough who demonstrated increased Ca permeability in a low pH environment (80).  
Acute effect of amino acids on total transepithelial 45Ca transport 
Our primary objective was to assess if amino acids have a direct effect on the enterocyte and 
thereby increase calcium transport. To assess the effect of amino acids on total transepithelial 
calcium transport, we first supplemented TB with an amount of amino acids comparable to that 
found in high glucose DMEM (Table), which we considered to be moderate in amino acid 
concentration (MAA). High glucose DMEM is the primary constituent of regular Caco-2 growth 
media and contains more amino acids than other commercially available media such as EMEM. 
For this reason we did not consider the amount of amino acids provided by the MAA treatment 
to be low or restrictive. Alternatively, we did not feel that this treatment provided additional 
amino acid supplementation above that provided by normal growth media. For these 
experiments we exposed the apical side or top of the monolayer and both the top and bottom 
sides of the monolayer to MAA. Exposing both sides of the Caco-2 monolayer to MAA for 6 
hours did not alter calcium transport compared to control (TB). However, the addition of MAA to 
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the top chamber resulted in a 1.6-fold increase in total transepithelial calcium transport (Figure 
4; P=0.069). As with most nutrient effects, the effect of MAA treatment appeared modest and 
was comparable to the previously reported trans-10, cis-12 conjugated linoleic acid-induced 2-
fold increase in total transepithelial 45Ca transport (25). Our in vivo experiments in both rats and 
humans examined intestinal Ca transport after 5-7 days of dietary protein supplementation. We 
therefore, were interested in whether a longer in vitro treatment period in our Caco-2 cell model 
would have a greater effect on total transepithelial transport. However, with longer treatment 
protocols the issue of nutrient deprivation in cells cultured in low amino acid conditions needed 
to be addressed. To resolve these concerns, the TB control was reformulated.  
Effect of prolonged amino acid supplementation on total transepithelial 45Ca transport: 
Preliminary Results 
Prolonged amino acid supplementation studies consisted of 72 hours of amino acid 
pretreatment followed by 6 hour assessment of total transepithelial Ca transport in the presence 
of glutamine, glycine and 12 additional EAA in TB (control) or HAA treatment (Table). The TB 
control used in these experiments differed from our original TB in that it contained glycine (0.03 
mg/mL) at a concentration identical to that found in high glucose DMEM and EAA (1.2 mg/mL), 
and provided a final concentration of 1.778 mg total amino acids/mL. As in our previous 
experiments, both conditions contained L-glutamine (a source of nitrogen for the synthesis of 
vitamins, amino acids and nucleotides), which is necessary for cell proliferation and 
differentiation. In nutrient-deprived states L-glutamine can be used for energy and maintenance 
of protein synthesis in Caco-2 cells (81-83). Thus, these experiments were designed to examine 
the effect of amino acid supplementation beyond the amount provided by normal growth media, 
and represents a better in vitro model for our human and animal studies (38, 58) than the acute 
amino acid transport experiments (described above). Prolonged amino acid supplementation 
significantly augmented total transepithelial Ca transport compared to control (Figure 5; 1.6-fold 
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increase; P=0.0048). These data are from one experiment and need to be repeated in order to 
confirm this potentially important finding.  
To date, it is unclear if amino acids exert an effect on the transcellular, paracellular or both 
calcium absorption pathways as our model cannot distinguish between these two transport 
mechanisms.  The microarray screen summarized in the Introduction raises the possibility that 
dietary protein or amino acids augment paracellular Ca transport by increasing expression of 
tight junction protein Cldn-2.  Since Cldn-2 is a Ca specific, pore-forming Cldn, it is reasonable 
to believe that Cldn-2 has a major role in Ca transport. In order to directly address this 
hypothesis, Cldn-2 was stably suppressed in Caco-2 cells and 45Ca transport studies were 
repeated. 
Confirmation of Cldn-2 knockdown in Caco-2 Cells 
qPCR analysis using RNA isolated from Caco-2 cells expressing shRNAs directed against Cldn-
2 demonstrated effective knockdown of Cldn-2,  with two of a panel of 5 shRNAs resulting in a ≥ 
88% suppression of the Cldn-2 transcript (Figure 6a-b). Western blot analysis revealed that 
shRNA 3 was the most effective shRNA (6c-d). Scrambled shRNA did not appear to alter the 
level of expression of Cldn-2 (6c-d), which suggests that lentiviral infection did not induce off-
target effects. GFP expression, a marker of transduction efficiency and shRNA expression, 
appeared relatively consistent between Caco-2 cells infected with scrambled and Cldn-2 
specific shRNAs (6e). 
Effect of stable Cldn-2 knockdown on total transepithelial 45Ca transport 
Of the 23 distinct Cldns identified in humans (84), Cldn-2 and -12  are characterized as Ca 
permissive tight junction proteins, which, through transient knockdown in Caco-2 cells, were 
proposed to be involved in 1,25-dihydroxyvitamin D-induced Ca transport (7). Overexpression of 
Cldn-2 and Cldn-12, but not Cldn-7 increased Ca transport in Caco-2 cells (7).  
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As shown in Figure 7, stable knockdown of Cldn-2 in post-confluent Caco-2 cells elicited more 
than a 3-fold reduction in total transepithelial Ca transport (P< 0.0001). To our knowledge we 
are the first to demonstrate an independent role for endogenous Cldn-2 in total transepithelial 
Ca transport in Caco-2 cells. Overexpression studies are inherently limited since they result in 
highly unphysiologic levels of the target protein. Our knockdown study establishes a role for 
Cldn-2 in Ca transport at endogenous levels in Caco-2 cells. It is not unreasonable to believe 
that Cldn-2 exhibits a functional role in intestinal Ca transport, as other members of the Cldn 
family are important mediators of Ca handling in other tissues. For example, under low dietary 
Ca conditions, Cldn-16 and -19 function together to form a Ca selective pore for reabsorption of 
Ca in the thick ascending limb of Henle. Conversely, when Ca intake is high, activation of the 
calcium sensing receptor results in upregulation of Cldn-14. Cldn-14, in turn, can interact with 
Cldn-16 to block Ca reabsorption and increase Ca excretion by the kidney (85).  Results from 
the present study provide further support for Cldn regulation of the Ca economy.  
As noted in the Introduction, we have initially focused on Cldn-2 based on the results of our 
microarray screen. Our Caco-2 cell line in which Cldn-2 was largely eliminated can now be used 
to examine the contribution of Cldn-2 to the effects of amino acids on total transepithiel Ca 
transport. It will also be of interest to investigate if diminished expression of Cldn-2 disrupts tight 
junction architecture or alters expression of other tight junction proteins such as cation pore 
sealers that could impede Ca permeability (4). 
Despite its several strengths, our in vitro model also has limitations. Post-confluent Caco-2 cells 
provide a well-established in vitro model of the small intestine, however, this model does not 
allow for differentiation between segments of the small intestine. In the Caco-2 cell model, the 
pH of the culture media was fixed between 7.37-7.4. As shown in Figure 3, pH has a profound 
effect on Ca permeability. Since the pH varies along the course of the small intestine our model 
does not adequately capture the pH influence on Ca transport (86). Lastly, our current model 
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cannot distinguish between transcellular and paracellular Ca transport. However, with the use of 
dyes such as lucifer yellow which is restricted to the extracellular space should in combination 
with 45Ca transport studies allow us to assess the contribution of paracellular Ca transport to the 
effect of amino acids on transepithielal Ca transport.  
Conclusion     
In summary, the current study established and validated an in vitro model for 45Ca transport. 
The model permitted an initial assessment of the direct effect of amino acids on total 
transepithelial Ca transport. A trend towards increased total transepithelial Ca transport was 
observed when the apical side of post-confluent Caco-2 cell monolayers was exposed to 
essential and non-essential amino acids for 6 hours. Preliminary results from prolonged amino 
acid treatment experiments showed significantly enhanced Ca transport, however, corroborative 
studies are warranted. In subsequent studies, the Caco-2 transport system was used to 
establish the role of endogenous Cldn-2 in total transepithelial Ca transport, and demonstrated 
a significant reduction in Ca transport when Cldn-2 was suppressed. This is the first study to 
generate a stable Cldn-2 knockdown in Caco-2 cells and provides evidence for role of Cldn-2 in 
Ca transport in the absence of pharmacologic or hormonal agonists. The present work will also 
allow us to directly address the contribution of Cldn-2 to amino acid-induced increases in Ca 
transport.   
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Table. Amino Acid Treatments 
Amino Acid (mg/mL) DMEM   MAA
1
   HAA
1,2
   
Glycine 0.030 
 
0.016 
 
0.085 
 L-Arginine hydrochloride 0.084 
 
0.263 
 
0.922 
 L-Cystine 2HCl 0.063 
 
0.050 
 
0.175 
 L-glutamine 0.584 
 
0.585 
 
0.585 
 L-Histidine hydrochloride H20 0.042 
 
0.088 
 
0.306 
 L-Isoleucine 0.105 
 
0.109 
 
0.382 
 L-Leucine 0.105 
 
0.109 
 
0.382 
 L-Lysine hydrochloride 0.146 
 
0.151 
 
0.529 
 L-Methionine 0.030 
 
0.031 
 
0.110 
 L-Phenylalanine 0.066 
 
0.069 
 
0.241 
 L-Serine 0.042 
 
0.022 
 
0.077 
 L-Threonine 0.095 
 
0.099 
 
0.347 
 L-Tryptophan 0.016 
 
0.021 
 
0.074 
 L-Tyrosine disodium salt dihydrate 0.104 
 
0.075 
 
0.263 
 L-Valine 0.094 
 
0.098 
 
0.341 
 L-Alanine 
  
0.019 
 
0.065 
 L-Asparagine 
  
0.028 
 
0.096 
 L-Aspartic Acid 
  
0.028 
 
0.097 
 L-Gutamic Acid 
  
0.031 
 
0.107 
 L-Proline 
  
0.024 
 
0.084 
 
       Total Amino Acids (mg/mL) 1.606 
 
1.914 
 
5.267 
               
1
Includes glutamine from transport buffer 
     2Includes glycine from transport buffer 
     MAA, moderate amino acid transport treatment 
    HAA, high amino acid transport treatment 
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Figure 1a-b. Relative diffusional phenol red transport (top to bottom) across monolayers of 
Caco-2 cells (Mooseker, approximately 21-day post confluent) at 90 and 120 min (1a) and 4 
hours (1b). n = 2 monolayers grown on collagen coated polytetrafluoroethylene  Transwell 
inserts exposed to transport buffer (TB, control) or 100 mM raffinose.  
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Figure 2. Total transepithelial 45Ca transport across monolayers of Caco-2 cells (Mooseker, 
approximately 13-17 days post confluences) at 4 hours.  Monolayers grown on polyester 
membrane Transwell inserts exposed to transport buffer (TB, control) for 4 hours or 1,25 vitamin 
D added to 5% FBS Caco-2 growth media for 24 hr prior to transport study and then added to 
TB 4 hr during transport study.  n=9 monolayers per condition. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Total transepithelial 45Ca transport across monolayers of Caco-2 cells (Mooseker, 26-
27 days in culture) at 6 hours. Monolayers grown on polyester membrane Transwell inserts 
exposed to transport buffer, pH of 7.37 (TB, control, n= 4) or acidic buffer, pH of 3 (added to the 
top chamber only, n= 3). 
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Figure 4. Total transepithelial 45Ca transport across monolayers of Caco-2 cells (Mooseker, 26 
days in culture) at 6 hours. Monolayers grown on polyester membrane Transwell inserts 
exposed to transport buffer (TB, control), moderate amino acid treatment (MAA, amino acids 
added to TB) on one side of the monolayer (MAA Top), or MAA on both sides of the monolayer 
(MAA Top and Bottom). n=3 monolayers per condition.  
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Figure 5. Monolayers grown on polyester membrane Transwell inserts (ATCC, 25 days in 
culture) pretreated with 1% FBS media (pretreatment control) or 1% FBS media supplemented 
with MAA (moderate amino acids) for 72 hours. Total transepithelial 45Ca transport at 6 hours in 
the presence of TB supplemented with glutamine, glycine and 12 additional essential amino 
acids (EAA) (control) or high amino acid treatment (HAA, amino acids added to control). 
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Figure 6a-f.  Confirmed knockdown efficiency of claudin-2 (Cldn-2) in Caco-2 cells by lentiviral shRNA 
(Moosker, 2-weeks post confluence). Non-infected Caco-2 cells (control), Caco-2 cells infected with non-
silencing, scrambled shRNA (control) or claudin-2 specific shRNAs. Confirmation of knockdown of Cldn-2 
by qPCR (a-b, control: GAPDH). Confirmation of knockdown of Cldn-2 by Western blot (β-actin used as a 
loading control, c). Relative expression of Cldn-2 in c normalized to β -actin, d). Caco-2 cells infected with 
scrambled shRNA (control) stably expressing GFP (e, left panels: fluorescent light, right panels: white 
light) or claudin-2 specific shRNA 3 stably expressing GFP (f, left panels: fluorescent light, right panels: 
white light) imaged by fluorescent microscopy.  
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Figure 7. Total transepithelial 
45
Ca transport across monolayers of Caco-2 cells infected with scrambled 
(control) or claudin-2 specific lentiviral shRNA (Mooseker, 25 days in culture). Transport assessed at 6 
hrs in transport buffer supplemented with glycine, glutamine and 12 additional essential amino acids 
(EAA). n=6 monolayers per condition. 
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Chapter 5: 
Conclusions and Future Study Directions 
 
We previously supplemented a low protein diet with dibasic amino acids and observed a trend 
towards increased Ca absoption in young women. Our sample size of 14 and six day study 
design may have hindered us from observing a statistically significant effect. Larger and longer 
clinical trials should provide more robust estimates of the magnitude of this effect and its 
duration. It would be of interest to explore the impact of dibasic amino acids along with other 
combinations of amino acids on calcium economy in populations who are at risk for calcium 
malabsorption. For example individuals with Crohn’s or celiac disease would benefit from non-
satiating, nutrient based, low-risk, nutritional therapies to optimize calcium absorption. 
Furthermore, individuals with protein intakes below the RDA may benefit from amino acid 
supplementation to improve Ca economy. Lastly, the effect of amino acid supplementation on 
Ca absorption may prove to be beneficial during critical stages in life such as infancy.   
We have established and validated an in vitro model for 45Ca transport in Caco-2 cells and have 
preliminary evidence to suggest that 72 hours of treatment with amino acid enriched media 
increases total transepithelial Ca transport. Future experiments will need to corroborate these 
findings. Our current manual method requires an approximately 25-day culture period and 
allows for up to 24-wells per experiment. Recent advances in culturing systems have decreased 
the required culturing period for Caco-2 cell differentiation to 3-7 days (87), allowing for 
increased efficiency and decreased risk of contamination. Furthermore, by collaborating with 
pharmaceutical companies we can automate this process with the use of a liquid handler and 
articulated arm (86), thereby increasing standardization and reducing inter- and intra-assay 
variability brought forth by human error. 
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Our current in vitro Ca transport system can be used in the future to assess the effect of 
different combinations and concentrations of amino acids on total transepithelial transport. 
Understanding the minimal amino acid requirements of Caco-2 cells will allow us to further 
improve our control treatment. We may be able to lower the amino acid concentration of our 
control without causing nutrient deprivation or damage, which could increase the magnitude of 
effect observed with amino acid supplementation. Cell viability studies and assessment of 
lactase dehydrogenase release after exposure to different amino acid concentrations will be 
informative in evaluating any potential cytoxic effects of our treatments. To better understand 
the contribution of paracellular Ca transport to the effect of amino acids on transepithelial 
transport, dyes such as lucifer yellow which is restricted to the extracellular space, can be 
included in our model.   
Data from our laboratory provide evidence for the role of Cldn-2 in total transepithelial Ca 
transport in vitro. We recently generated a stable Cldn-2 knockdown cell line and observed a 
significant decline in total transepithelial Ca transport.  We plan to use this model to address the 
contribution of Cldn-2 to amino acid-induced increases in Ca transport. In order to corroborate 
our in vitro findings, it is necessary to explore the role of Cldn-2 in Ca transport in vivo.  This 
would require conditional deletion of Cldn-2 in a mouse model.  For theses experiment, Villin-cre 
transgenic mice (JAX® Mice database, B6.SJL-Tg(Vil-cre)997Gum/J), who express Cre 
recombinase under the direction of the mouse villin 1 promoter, would be crossed with a strain 
containing a loxP site-flanked sequence for Cldn-2. Cre-mediated recombination would allow for 
tissue-specific deletion of Cldn-2. Recombination would occur in villi and crypt cells of the small 
and large intestines, thereby generating gut-specific gene-deficient mice for Cldn-2. Ca 
absorption could be assessed by 45Ca skeletal incorporation. 
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